现代中药集团有限公司2024年报:股权激励计划保持授权上限

公告速递
Dec 18, 2025

本季度信息

现代中药集团有限公司(股份代号:1643)在其2024年年报中披露,公司的股权激励计划仍保持最高可授权限额。根据该计划,可供发行的股份总数为60,000,000股,占2024年年报日期公司当时全部已发行股本的10%。董事会在授予期权时可自行全权厘定行权期限,最长期限为自相关期权授予日起计十年。自该计划设立以来,截至2024年年初和年末,公司从未根据该计划授予任何期权,可供授予的期权数量保持在60,000,000份。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10